Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968889435> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2968889435 endingPage "105041" @default.
- W2968889435 startingPage "105041" @default.
- W2968889435 abstract "NEPA is the fixed combination antiemetic composed of the neurokinin-1 receptor antagonist netupitant and the 5-hydroxytryptamine-3 receptor antagonist palonosetron. The intravenous (i.v.) formulation of NEPA (fosnetupitant 235 mg/palonosetron 0.25 mg) was developed to enhance the convenience of NEPA administration. In a phase 3 study, i.v. NEPA showed acceptable safety with low risk for injection-site reactions. This study evaluated the pharmacokinetics and safety of i.v. NEPA in cancer patients. This was a single-center, single-dose phase 1 study in patients receiving highly emetogenic chemotherapy. Patients received a 30-min infusion of i.v. NEPA plus oral dexamethasone (12 mg) prior to chemotherapy, and oral dexamethasone (8 mg/daily) on days 2–4. Twenty-four patients received the complete i.v. NEPA infusion volume. Fosnetupitant maximum plasma concentration (Cmax) was reached at the end of infusion and decreased to <1% of Cmax 30 min later. Netupitant was rapidly released from its prodrug and Cmax of 590 ng/ml was reached at the end of fosnetupitant infusion, with a mean exposure (AUC∞) of 15,588 h∙ng/ml. Palonosetron Cmax was reached at the end of infusion, with a mean AUC∞ of 36.07 h∙ng/ml. The most common adverse events were constipation (29%), nausea (17%), and vasospasm (8%). No i.v. NEPA-related injection site reactions occurred. Fosnetupitant conversion to netupitant occurred rapidly in cancer patients. Netupitant and palonosetron pharmacokinetic profiles in i.v. NEPA were similar to those reported for oral NEPA. i.v. NEPA was well tolerated with a similar safety profile to oral NEPA. i.v. NEPA provides additional administration convenience. Clinical trial registration number: EudraCT 2015-004750-18." @default.
- W2968889435 created "2019-08-22" @default.
- W2968889435 creator A5004039781 @default.
- W2968889435 creator A5024702587 @default.
- W2968889435 creator A5049565576 @default.
- W2968889435 creator A5076030498 @default.
- W2968889435 creator A5086782544 @default.
- W2968889435 creator A5089913815 @default.
- W2968889435 date "2019-11-01" @default.
- W2968889435 modified "2023-10-14" @default.
- W2968889435 title "Pharmacokinetic profile and safety of intravenous NEPA, a fixed combination of fosnetupitant and palonosetron, in cancer patients: Prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy" @default.
- W2968889435 cites W1543455180 @default.
- W2968889435 cites W1964623352 @default.
- W2968889435 cites W1974362328 @default.
- W2968889435 cites W2005339341 @default.
- W2968889435 cites W2018091080 @default.
- W2968889435 cites W2037750236 @default.
- W2968889435 cites W2086112274 @default.
- W2968889435 cites W2098832321 @default.
- W2968889435 cites W2120970263 @default.
- W2968889435 cites W2133300915 @default.
- W2968889435 cites W2146684659 @default.
- W2968889435 cites W2156319350 @default.
- W2968889435 cites W2162984217 @default.
- W2968889435 cites W2195040438 @default.
- W2968889435 cites W2527377692 @default.
- W2968889435 cites W2555438743 @default.
- W2968889435 cites W2604708549 @default.
- W2968889435 cites W2613201674 @default.
- W2968889435 cites W2620925856 @default.
- W2968889435 cites W2751763900 @default.
- W2968889435 cites W2770954052 @default.
- W2968889435 cites W2802988624 @default.
- W2968889435 cites W2889822187 @default.
- W2968889435 cites W2897926111 @default.
- W2968889435 cites W2900387869 @default.
- W2968889435 cites W2916840282 @default.
- W2968889435 cites W4243894673 @default.
- W2968889435 doi "https://doi.org/10.1016/j.ejps.2019.105041" @default.
- W2968889435 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31404621" @default.
- W2968889435 hasPublicationYear "2019" @default.
- W2968889435 type Work @default.
- W2968889435 sameAs 2968889435 @default.
- W2968889435 citedByCount "4" @default.
- W2968889435 countsByYear W29688894352019 @default.
- W2968889435 countsByYear W29688894352020 @default.
- W2968889435 countsByYear W29688894352022 @default.
- W2968889435 countsByYear W29688894352023 @default.
- W2968889435 crossrefType "journal-article" @default.
- W2968889435 hasAuthorship W2968889435A5004039781 @default.
- W2968889435 hasAuthorship W2968889435A5024702587 @default.
- W2968889435 hasAuthorship W2968889435A5049565576 @default.
- W2968889435 hasAuthorship W2968889435A5076030498 @default.
- W2968889435 hasAuthorship W2968889435A5086782544 @default.
- W2968889435 hasAuthorship W2968889435A5089913815 @default.
- W2968889435 hasConcept C112705442 @default.
- W2968889435 hasConcept C22979827 @default.
- W2968889435 hasConcept C2776712918 @default.
- W2968889435 hasConcept C2779924295 @default.
- W2968889435 hasConcept C2780574406 @default.
- W2968889435 hasConcept C2780852908 @default.
- W2968889435 hasConcept C2780884295 @default.
- W2968889435 hasConcept C42219234 @default.
- W2968889435 hasConcept C71924100 @default.
- W2968889435 hasConcept C98274493 @default.
- W2968889435 hasConceptScore W2968889435C112705442 @default.
- W2968889435 hasConceptScore W2968889435C22979827 @default.
- W2968889435 hasConceptScore W2968889435C2776712918 @default.
- W2968889435 hasConceptScore W2968889435C2779924295 @default.
- W2968889435 hasConceptScore W2968889435C2780574406 @default.
- W2968889435 hasConceptScore W2968889435C2780852908 @default.
- W2968889435 hasConceptScore W2968889435C2780884295 @default.
- W2968889435 hasConceptScore W2968889435C42219234 @default.
- W2968889435 hasConceptScore W2968889435C71924100 @default.
- W2968889435 hasConceptScore W2968889435C98274493 @default.
- W2968889435 hasFunder F4320310276 @default.
- W2968889435 hasLocation W29688894351 @default.
- W2968889435 hasLocation W29688894352 @default.
- W2968889435 hasOpenAccess W2968889435 @default.
- W2968889435 hasPrimaryLocation W29688894351 @default.
- W2968889435 hasRelatedWork W100286279 @default.
- W2968889435 hasRelatedWork W1480067006 @default.
- W2968889435 hasRelatedWork W2052445101 @default.
- W2968889435 hasRelatedWork W2057039455 @default.
- W2968889435 hasRelatedWork W2151415185 @default.
- W2968889435 hasRelatedWork W2155434997 @default.
- W2968889435 hasRelatedWork W2903526783 @default.
- W2968889435 hasRelatedWork W3096722963 @default.
- W2968889435 hasRelatedWork W3202914524 @default.
- W2968889435 hasRelatedWork W4245250147 @default.
- W2968889435 hasVolume "139" @default.
- W2968889435 isParatext "false" @default.
- W2968889435 isRetracted "false" @default.
- W2968889435 magId "2968889435" @default.
- W2968889435 workType "article" @default.